Difference between revisions of "Part:BBa K3113100"

Line 21: Line 21:
 
<html>
 
<html>
 
<figure class="figure">
 
<figure class="figure">
<img src="https://2019.igem.org/wiki/images/e/e4/T--Munich--Gag.png" width="400" height="300" class="figure-img img-fluid rounded" alt="A generic square placeholder image with rounded corners in a figure.">
+
<img src="https://2019.igem.org/wiki/images/e/e4/T--Munich--Gag.png" width="400" height="320" class="figure-img img-fluid rounded" alt="A generic square placeholder image with rounded corners in a figure.">
 
<figcaption class="figure-caption">The structure of the viral Gag polyprotein.   
 
<figcaption class="figure-caption">The structure of the viral Gag polyprotein.   
 
</figcaption>
 
</figcaption>

Revision as of 07:02, 21 October 2019


Gag HIV-1

This sequence codes for the coat protein of the human immunodeficiency virus, which mediates the essential events in virion assembly, including binding the plasma membrane, making the protein-protein interactions necessary to create spherical particles.


Usage

For ALiVE, two vesicles were tested. One kind of vesicle is based on the Gag-p24 capsid protein of HIV. We used this protein fused together with RNA binding proteins to build and load virus-like vesicles for non-invasive cell monitoring.


Biologie

Gag-p24 is the group-specific antigen from the lentivirus HIV. It assembles at the plasma membrane and leads to the budding of vesicles.[1]


Characterization

Protein Structure

A generic square placeholder image with rounded corners in a figure.
The structure of the viral Gag polyprotein.

Sequence and Features


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    COMPATIBLE WITH RFC[12]
  • 21
    INCOMPATIBLE WITH RFC[21]
    Illegal BglII site found at 1307
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    COMPATIBLE WITH RFC[25]
  • 1000
    INCOMPATIBLE WITH RFC[1000]
    Illegal BsaI.rc site found at 607


References

  1. HIV-1 Gag: a Molecular Machine Driving Viral Particle Assembly and Release Heinrich G. Göttlinger Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, and Department of Pathology, Harvard Medical School, Boston